반응식
[O:1]=[C:2]([C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1)[C@@H:3]([NH:7][C:8](=[O:14])[O:9][C:10]([CH3:13])([CH3:12])[CH3:11])[CH2:4][CH2:5][CH3:6].[CH3:21][O:22]N(C)C(=O)[C@@H](NC(=O)OC(C)(C)C)CCC>>[CH3:21][O:22][C:19]1[CH:20]=[C:15]([C:2](=[O:1])[C@@H:3]([NH:7][C:8](=[O:14])[O:9][C:10]([CH3:12])([CH3:13])[CH3:11])[CH2:4][CH2:5][CH3:6])[CH:16]=[CH:17][CH:18]=1참가 물질
3
실험 절차
was synthesised in the same way as (91c) from (S)-tert-butyl 1-(methoxy(methyl)amino)-1-oxopentan-2-ylcarbamate (91d, 250 mg, 0.96 mmol).
출처 및 근거
- ORD 기록
- ord-c3be4b1ddbde455aab1a0b80ab22a37d
- 출처 데이터셋
- uspto-grants-2010_06
- 특허 번호
- US07728030B2
연결된 노트
불러오는 중…